Horst & Graben Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $236K | Buy |
1,273
+19
| +2% | +$3.53K | 0.04% | 155 |
|
2025
Q1 | $263K | Buy |
1,254
+106
| +9% | +$22.2K | 0.05% | 129 |
|
2024
Q4 | $204K | Buy |
1,148
+5
| +0.4% | +$888 | 0.04% | 151 |
|
2024
Q3 | $226K | Buy |
+1,143
| New | +$226K | 0.04% | 143 |
|
2023
Q4 | – | Sell |
-1,412
| Closed | -$210K | – | 137 |
|
2023
Q3 | $210K | Buy |
+1,412
| New | +$210K | 0.05% | 125 |
|
2023
Q2 | – | Sell |
-1,366
| Closed | -$218K | – | 131 |
|
2023
Q1 | $218K | Buy |
1,366
+10
| +0.7% | +$1.6K | 0.05% | 121 |
|
2022
Q4 | $219K | Buy |
+1,356
| New | +$219K | 0.06% | 120 |
|
2022
Q3 | – | Sell |
-1,336
| Closed | -$205K | – | 124 |
|
2022
Q2 | $205K | Buy |
1,336
+9
| +0.7% | +$1.38K | 0.06% | 124 |
|
2022
Q1 | $215K | Buy |
+1,327
| New | +$215K | 0.05% | 125 |
|